{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:54:47Z","timestamp":1792652087373,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Transmission of canine heartworm (<jats:italic>Dirofilaria immitis<\/jats:italic>) from infected to na\u00efve dogs is dependent on successful mosquito feeding and survival.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>To determine whether treating heartworm-infected dogs with fluralaner (Bravecto<jats:sup>\u00ae<\/jats:sup>) limits the survival of infected mosquitoes, and potentially the transmission of <jats:italic>D. immitis<\/jats:italic>, we allowed female mosquitoes to feed on microfilaremic dogs and evaluated mosquito survival and infection with <jats:italic>D. immitis<\/jats:italic>. Eight dogs were experimentally infected with <jats:italic>D. immitis<\/jats:italic>. On day 0 (~\u200911\u00a0months post-infection), four microfilaremic dogs were treated with fluralaner according to label directions while the other four were non-treated controls. Mosquitoes (<jats:italic>Aedes aegypti<\/jats:italic> Liverpool) were allowed to feed on each dog on days \u22127, 2, 30, 56, and 84. Fed mosquitoes were collected, and the number of live mosquitoes determined at 6\u00a0h, 24\u00a0h, 48\u00a0h, and 72\u00a0h post-feeding. Surviving mosquitoes held for 2\u00a0weeks were dissected to confirm third-stage <jats:italic>D. immitis<\/jats:italic> larvae; PCR (12S rRNA gene) was performed post-dissection to identify <jats:italic>D. immitis<\/jats:italic> in mosquitoes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Prior to treatment, 98.4%, 85.1%, 60.7%, and 40.3% of mosquitoes fed on microfilaremic dogs were alive at 6\u00a0h, 24\u00a0h, 48\u00a0h, and 72\u00a0h post-feeding, respectively. Similarly, mosquitoes fed on microfilaremic, non-treated dogs were alive 6\u00a0h post-feeding (98.5\u2013100%) throughout the study. In contrast, mosquitoes fed on fluralaner-treated dogs 2\u00a0days after treatment were dead or severely moribund by 6\u00a0h post-feeding. At 30 and 56 days post-treatment,\u2009&gt;\u200999% of mosquitoes fed on treated dogs were dead by 24\u00a0h. At 84\u00a0days post-treatment, 98.4% of mosquitoes fed on treated dogs were dead by 24\u00a0h. Before treatment, third-stage larvae of <jats:italic>D. immitis<\/jats:italic> were recovered from 15.5% of <jats:italic>Ae. aegypti<\/jats:italic> 2\u00a0weeks after feeding, and 72.4% were positive for <jats:italic>D. immitis<\/jats:italic> by PCR. Similarly, 17.7% of mosquitoes fed on non-treated dogs had <jats:italic>D. immitis<\/jats:italic> third-stage larvae 2 weeks after feeding, and 88.2% were positive by PCR. Five mosquitoes fed on fluralaner-treated dogs survived 2\u00a0weeks post-feeding, and 4\/5 were from day 84. None had third-stage larvae at dissection, and all were PCR-negative.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The data indicate that fluralaner treatment of dogs kills mosquitoes and thus would be expected to reduce transmission of heartworm in the surrounding community.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s13071-023-05819-9","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T16:02:43Z","timestamp":1687276963000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Fluralaner (Bravecto\u00ae) treatment kills Aedes aegypti after feeding on Dirofilaria immitis-infected dogs"],"prefix":"10.1186","volume":"16","author":[{"given":"Kathryn","family":"Duncan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne W.","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellee D.","family":"Sundstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Guerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"key":"5819_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/1756-3305-7-83","volume":"7","author":"N Rohdich","year":"2014","unstructured":"Rohdich N, Roepke RK, Zschiesche E. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto (fluralaner) against Frontline (fipronil) in flea- and tick-infested dogs. Parasit Vectors. 2014;7:83.","journal-title":"Parasit Vectors"},{"key":"5819_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13071-017-1971-5","volume":"10","author":"C Meadows","year":"2017","unstructured":"Meadows C, Guerino F, Sun F. A randomized, blinded, controlled USA field study to assess the use of fluralaner topical solution in controlling canine flea infestations. Parasit Vectors. 2017;10:36.","journal-title":"Parasit Vectors"},{"key":"5819_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/s13071-020-04179-y","volume":"13","author":"K Allen","year":"2020","unstructured":"Allen K, Little S, Petersen M, Gruntmeir J, Barrett A, Herrin B, et al. Evaluation of oral fluralaner (Bravecto\u00ae) for efficacy against nymphs of Amblyomma americanum and Rhipicephalus sanguineus (sensu lato). Parasit Vectors. 2020;13:315.","journal-title":"Parasit Vectors"},{"key":"5819_CR4","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s13071-015-0965-4","volume":"8","author":"MW Dryden","year":"2015","unstructured":"Dryden MW, Smith V, Bennett T, Math L, Kallman J, Heaney K, et al. Efficacy of fluralaner flavored chews (Bravecto) administered to dogs against the adult cat flea, Ctenocephalides felis felis and egg production. Parasit Vectors. 2015;8:364.","journal-title":"Parasit Vectors"},{"key":"5819_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13071-015-0864-8","volume":"8","author":"P Fisara","year":"2015","unstructured":"Fisara P, Webster M. A randomized controlled trial of the efficacy of orally administered fluralaner (Bravecto\u2122) against induced Ixodes holocyclus (Australian paralysis tick) infestations on dogs. Parasit Vectors. 2015;8:257.","journal-title":"Parasit Vectors"},{"key":"5819_CR6","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s13071-015-0923-1","volume":"8","author":"J Taenzler","year":"2015","unstructured":"Taenzler J, Liebenberg J, Roepke RK, Heckeroth AR. Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto\u2122). Parasit Vectors. 2015;8:305.","journal-title":"Parasit Vectors"},{"key":"5819_CR7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1186\/s13071-018-3140-x","volume":"11","author":"D Gopinath","year":"2018","unstructured":"Gopinath D, Meyer L, Smith J, Armstrong R. Topical or oral fluralaner efficacy against flea (Ctenocephalides felis) transmission of Dipylidium caninum infection to dogs. Parasit Vectors. 2018;11:557.","journal-title":"Parasit Vectors"},{"key":"5819_CR8","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/ijerph14020154","volume":"14","author":"S Jiang","year":"2017","unstructured":"Jiang S, Tsikolia M, Bernier UR, Bloomquist JR. Mosquitocidal activity and mode of action of the isoxazoline fluralaner. Int J Environ Res Public Health. 2017;14:154.","journal-title":"Int J Environ Res Public Health"},{"key":"5819_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1186\/s13071-017-2344-9","volume":"10","author":"H Kohler-Aanesen","year":"2017","unstructured":"Kohler-Aanesen H, Saari S, Armstrong R, P\u00e9r\u00e9 K, Taenzler J, Zschiesche E, et al. Efficacy of fluralaner (Bravecto\u2122 chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs. Parasit Vectors. 2017;10:426.","journal-title":"Parasit Vectors"},{"key":"5819_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s13071-016-1954-y","volume":"10","author":"J Taenzler","year":"2017","unstructured":"Taenzler J, de Vos C, Roepke RK, Fr\u00e9nais R, Heckeroth AR. Efficacy of fluralaner against Otodectes cynotis infestations in dogs and cats. Parasit Vectors. 2017;10:30.","journal-title":"Parasit Vectors"},{"key":"5819_CR11","doi-asserted-by":"publisher","first-page":"E6920","DOI":"10.1073\/pnas.1801338115","volume":"115","author":"M Miglianico","year":"2018","unstructured":"Miglianico M, Eldering M, Slater H, Ferguson N, Ambrose P, Lees RS, et al. Repurposing isoxazoline veterinary drugs for control of vector-borne human diseases. Proc Natl Acad Sci USA. 2018;115:E6920\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"5819_CR12","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13071-022-05213-x","volume":"15","author":"N Rohdich","year":"2022","unstructured":"Rohdich N, Meyer L, Guerino F. Fluralaner 5.46% (w\/w) flavored chewable tablet (Bravecto\u00ae 1-month) is effective for treatment of canine generalized demodicosis. Parasit Vectors. 2022;15:83.","journal-title":"Parasit Vectors"},{"key":"5819_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13071-023-05682-8","volume":"16","author":"CC Evans","year":"2023","unstructured":"Evans CC, Normile D, Gamble S, Guerino F, Dzimianski MT, Moorhead AR. Treatment of dogs with Bravecto\u00ae (fluralaner) reduces mosquito survival and fecundity. Parasit Vectors. 2023;16:147.","journal-title":"Parasit Vectors"},{"key":"5819_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ijpddr.2021.03.004","volume":"16","author":"S Noack","year":"2021","unstructured":"Noack S, Harrington J, Carithers DS, Kaminsky R, Selzer PM. Heartworm disease\u2014overview, intervention, and industry perspective. Int J Parasitol Drugs Drug Resist. 2021;16:65\u201389.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5819_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1053\/j.tcam.2011.09.005","volume":"26","author":"N Ledesma","year":"2011","unstructured":"Ledesma N, Harrington L. Mosquito vectors of dog heartworm in the United States: vector status and factors influencing transmission efficiency. Top Companion Anim Med. 2011;26:178\u201385.","journal-title":"Top Companion Anim Med"},{"key":"5819_CR16","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s13071-019-3633-2","volume":"12","author":"SW Self","year":"2019","unstructured":"Self SW, Pulaski CN, McMahan CS, Brown DA, Yabsley MJ, Gettings JR. Regional and local temporal trends in the prevalence of canine heartworm infection in the contiguous United States: 2012\u20132018. Parasit Vectors. 2019;12:380.","journal-title":"Parasit Vectors"},{"key":"5819_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13071-018-2631-0","volume":"11","author":"J Drake","year":"2018","unstructured":"Drake J, Wiseman S. Increasing incidence of Dirofilaria immitis in dogs in USA with focus on the southeast region 2013\u20132016. Parasit Vectors. 2018;11:39.","journal-title":"Parasit Vectors"},{"key":"5819_CR18","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.vetpar.2009.03.026","volume":"163","author":"C Genchi","year":"2009","unstructured":"Genchi C, Rinaldi L, Mortarino M, Genchi M, Cringoli G. Climate and Dirofilaria infection in Europe. Vet Parasitol. 2009;163:286\u201392.","journal-title":"Vet Parasitol"},{"key":"5819_CR19","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.vetpar.2015.04.002","volume":"210","author":"C Bourguinat","year":"2015","unstructured":"Bourguinat C, Lee AC, Lizundia R, Blagburn BL, Liotta JL, Kraus MS, et al. Macrocyclic lactone resistance in Dirofilaria immitis: Failure of heartworm preventives and investigation of genetic markers for resistance. Vet Parasitol. 2015;210:167\u201378.","journal-title":"Vet Parasitol"},{"key":"5819_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.ijpara.2021.08.006","volume":"51","author":"RK Prichard","year":"2021","unstructured":"Prichard RK. Macrocyclic lactone resistance in Dirofilaria immitis: risks for prevention of heartworm disease. Int J Parasitol. 2021;51:1121\u201332.","journal-title":"Int J Parasitol"},{"key":"5819_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0065-308X(08)00204-2","volume":"66","author":"JW McCall","year":"2008","unstructured":"McCall JW, Genchi C, Kramer LH, Guerrero J, Venco L. Heartworm disease in animals and humans. Adv Parasit. 2008;66:193\u2013285.","journal-title":"Adv Parasit"},{"key":"5819_CR22","volume-title":"Veterinary clinical parasitology","author":"A Zajac","year":"2021","unstructured":"Zajac A, Conboy G, Little SE, Reichard MV. Veterinary clinical parasitology. 9th ed. Oxford: Blackwell Publishing; 2021.","edition":"9"},{"key":"5819_CR23","unstructured":"McCall JW, Lindemann BA, Porter CA, OttoG F. Proceedings of the Heartworm Symposium 1980. Edwardsville, KS: Veterinary Medicine Publishing Co; 1980. Prophylactic activity of avermectins against experimentally induced\u2009Dirofilaria immitis infections in dogs; pp. 126\u2013130."},{"key":"5819_CR24","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13071-018-2736-5","volume":"1","author":"S Little","year":"2018","unstructured":"Little S, Saleh M, Wohltjen M, Nagamori Y. Prime detection of Dirofilaria immitis: understanding the influence of blocked antigen on heartworm test performance. Parasit Vectors. 2018;1:186.","journal-title":"Parasit Vectors"},{"key":"5819_CR25","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1186\/s13071-017-2439-3","volume":"10","author":"JW McCall","year":"2017","unstructured":"McCall JW, Hodgkins E, Varloud M, Mansour A, DiCosty U. Blocking the transmission of heartworm (Dirofilaria immitis) to mosquitoes (Aedes aegypti) by weekly exposure for one month to microfilaremic dogs treated once topically with dinotefuran-permethrin-pyriproxyfen. Parasit Vectors. 2017;10:511.","journal-title":"Parasit Vectors"},{"key":"5819_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12917-020-02622-x","volume":"16","author":"D Tahir","year":"2020","unstructured":"Tahir D, Meyer LN, Lekouch N, Varloud M. Aedes (Stegomyia) aegypti mosquito bite hypersensitivity in a dog: a case report. BMC Vet Res. 2020;16:402.","journal-title":"BMC Vet Res"},{"key":"5819_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1017\/S0022149X00020307","volume":"34","author":"AE Taylor","year":"1960","unstructured":"Taylor AE. The development of Dirofilaria immitis in the mosquito Aedes aegypti. J Helminthol. 1960;34:27\u201338.","journal-title":"J Helminthol"},{"key":"5819_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.vetpar.2011.05.043","volume":"182","author":"D Otranto","year":"2011","unstructured":"Otranto D, Brianti E, Dantas-Torres F, Weigl S, Latrofa MS, Gaglio G, et al. Morphological and molecular data on the dermal microfilariae of a species of Cercopithifilaria from a dog in Sicily. Vet Parasitol. 2011;182:221\u20139.","journal-title":"Vet Parasitol"},{"key":"5819_CR29","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1051\/parasite\/2017042","volume":"24","author":"J Liebenberg","year":"2017","unstructured":"Liebenberg J, Fourie J, Lebon W, Larsen D, Halos L, Beugnet F. Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard\u00ae. Parasite. 2017;24:39.","journal-title":"Parasite"},{"key":"5819_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13071-023-05699-z","volume":"16","author":"T Geurden","year":"2023","unstructured":"Geurden T, Chapin S, McCall JW, Mansour A, Mahabir SP, Kryda K, et al. Insecticidal activity of Simparica and Simparica Trio against Aedes aegypti in dogs. Parasit Vectors. 2023;16:95.","journal-title":"Parasit Vectors"},{"key":"5819_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0304-4017(00)00242-9","volume":"90","author":"CH Lai","year":"2000","unstructured":"Lai CH, Tung KC, Ooi HK, Wang JS. Competence of Aedes albopictus and Culex quinquefasciatus as vector of Dirofilaria immitis after blood meal with different microfilarial density. Vet Parasitol. 2000;90:231\u20137.","journal-title":"Vet Parasitol"},{"key":"5819_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jvp.12959","volume":"45","author":"X Zhou","year":"2022","unstructured":"Zhou X, Hohman AE, Hsu WH. Current review of isoxazoline ectoparasiticides used in veterinary medicine. J Vet Pharmacol Ther. 2022;45:1\u201315.","journal-title":"J Vet Pharmacol Ther"},{"key":"5819_CR33","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1756-3305-7-85","volume":"7","author":"S Kilp","year":"2014","unstructured":"Kilp S, Ramirez D, Allan MJ, Roepke RK, Nuernberger MC. Pharmacokinetics of fluralaner in dogs following a single oral or intravenous administration. Parasit Vectors. 2014;7:85.","journal-title":"Parasit Vectors"},{"key":"5819_CR34","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1186\/s13071-017-2445-5","volume":"10","author":"J Carmichael","year":"2017","unstructured":"Carmichael J, McCall S, DiCosty U, Mansour A, Roycroft L. Evaluation of Dirofilaria immitis antigen detection comparing heated and unheated serum in dogs with experimental heartworm infections. Parasit Vectors. 2017;10:486.","journal-title":"Parasit Vectors"},{"key":"5819_CR35","first-page":"133","volume":"163","author":"MM Wong","year":"1973","unstructured":"Wong MM, Suter PF, Rhode EA, Guest MF. Dirofilariasis without circulating microfilariae: a problem in diagnosis. J Am Vet Med Assoc. 1973;163:133\u20139.","journal-title":"J Am Vet Med Assoc"},{"key":"5819_CR36","first-page":"1323","volume":"180","author":"CA Rawlings","year":"1982","unstructured":"Rawlings CA, Dawe DL, McCall JW, Keith JC, Prestwood AK. Four types of occult Dirofilaria immitis infection in dogs. J Am Vet Med Assoc. 1982;180:1323\u20136.","journal-title":"J Am Vet Med Assoc"},{"key":"5819_CR37","first-page":"414","volume":"40","author":"MM Wong","year":"1979","unstructured":"Wong MM, Suter PF. Indirect fluorescent antibody test in occult dirofilariasis. Am J Vet Res. 1979;40:414\u201320.","journal-title":"Am J Vet Res"},{"key":"5819_CR38","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.vetimm.2006.10.004","volume":"115","author":"R Morch\u00f3n","year":"2007","unstructured":"Morch\u00f3n R, L\u00f3pez-Belmonte J, Bazzocchi C, Grandi G, Kramer L, Sim\u00f3n F. Dogs with patent Dirofilaria immitis infection have higher expression of circulating IL-4, IL-10 and iNOS mRNA than those with occult infection. Vet Immunol Immunopathol. 2007;115:184\u20138.","journal-title":"Vet Immunol Immunopathol"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05819-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-023-05819-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-023-05819-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T16:08:27Z","timestamp":1687277307000},"score":1,"resource":{"primary":{"URL":"https:\/\/parasitesandvectors.biomedcentral.com\/articles\/10.1186\/s13071-023-05819-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5819"],"URL":"https:\/\/doi.org\/10.1186\/s13071-023-05819-9","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiments reported were conducted in accordance with the Oklahoma State University Institutional Animal Care and Use Committee (IACUC) under an approved Animal Care and Use Protocol (IACUC-19\u201353; approved September 3, 2019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"KD, AB, and FG are employees of Merck Animal Health (Rahway, NJ, USA). SL has received honoraria and research support from multiple veterinary pharmaceutical companies that manufacture ectoparasite control products. KS declares no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"208"}}